AA
SGMO

ALPS Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

ALPS Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-178,133
Closed -$1.6M – 967
2021
Q3 		$1.6M Sell
178,133
-11,385
-6% -$113K 0.02% 342
2021
Q2 		$2.27M Sell
189,518
-66,376
-26% -$752K 0.02% 290
2021
Q1 		$3.21M Buy
255,894
+1,058
+0.4% +$14.3K 0.03% 210
2020
Q4 		$3.98M Buy
+254,836
New +$2.99M 0.04% 190

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ALPS Advisors's SGMO Position: Q4 2021 in Review

ALPS Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 178,133 shares — an estimated $1.6M sold.

ALPS Advisors first reported a position in SGMO in Q4 2020 and held it in 4 quarters. The position peaked at $3.98M in Q4 2020. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

  • ALPS Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • ALPS Advisors sold 178,133 SANGAMO THERAPEUTICS INC shares in Q4 2021, an estimated $1.6M.
  • ALPS Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q4 2020 and held it in 4 quarters.
  • ALPS Advisors's SANGAMO THERAPEUTICS INC position peaked at $3.98M in Q4 2020.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.